FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899585536> ?p ?o ?g. }

• W2899585536 endingPage "356" @default.
• W2899585536 startingPage "349" @default.
• W2899585536 abstract "Purpose To determine the relationship between target lesion selection with use of Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 and classification of therapeutic response in patients with metastatic cancer undergoing systemic cytotoxic and/or targeted therapies. Materials and Methods This prospective multireader study was conducted between July 2015 and July 2017. Three hundred sixteen consecutive participants with metastatic cancer underwent 932 CT examinations to monitor systemic treatment. CT studies were independently read by three radiologists. Readers identified a maximum of five lesions total (and a maximum of two lesions per organ). Dedicated oncology tumor response software was used. The Fleiss κ statistic was used to analyze interreader agreement in the assignment of individual response classes (complete response, partial response, progressive disease, or stable disease) and in the differentiation between progressive and nonprogressive disease. Results Readers selected the same set of target lesions in 128 of the 316 participants (41%) and selected a different set in 188 (59%). When target lesion selection was concordant, agreement was high (assignment of treatment response category: κ = 0.97; 95% confidence interval [CI]: 0.91, 1.0; differentiation between progressive and nonprogressive disease: κ = 0.98; 95% CI: 0.90, 1.0). When target lesion selection was discordant, agreement was significantly reduced (assignment of treatment response category: κ = 0.58; 95% CI: 0.54, 0.62; differentiation between progressive and nonprogressive disease: κ = 0.6; 95% CI: 0.59, 0.70). With concordant target lesion selection, readers agreed regarding diagnosis of progression in 97.7% of participants (95% CI: 95.4%, 100.0%); with discordant target lesion selection, readers agreed in only 55.3% (95% CI: 47.9%, 62.6%) (P < .01). Conclusion In patients with metastatic cancer undergoing systemic treatment, different cancer sites may appear similarly suitable and thus likely to be selected as target lesions but may yield inconsistent or even conflicting results with Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. This indicates that the current, limited set of target lesions in RECIST 1.1 may not reflect overall tumor load or response to therapy. © RSNA, 2018 See also the editorial by Sosna in this issue." @default.
• W2899585536 created "2018-11-16" @default.
• W2899585536 creator A5004120899 @default.
• W2899585536 creator A5012119257 @default.
• W2899585536 creator A5024657373 @default.
• W2899585536 creator A5033299279 @default.
• W2899585536 creator A5037042906 @default.
• W2899585536 creator A5070612619 @default.
• W2899585536 creator A5072853954 @default.
• W2899585536 date "2019-02-01" @default.
• W2899585536 modified "2023-10-14" @default.
• W2899585536 title "Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study" @default.
• W2899585536 cites W1531457459 @default.
• W2899585536 cites W192377094 @default.
• W2899585536 cites W1973942156 @default.
• W2899585536 cites W1979988663 @default.
• W2899585536 cites W1991801291 @default.
• W2899585536 cites W1992642679 @default.
• W2899585536 cites W1992878126 @default.
• W2899585536 cites W1995071000 @default.
• W2899585536 cites W2019607817 @default.
• W2899585536 cites W2027750830 @default.
• W2899585536 cites W2039010280 @default.
• W2899585536 cites W2053956459 @default.
• W2899585536 cites W2075351817 @default.
• W2899585536 cites W2096900586 @default.
• W2899585536 cites W2105746319 @default.
• W2899585536 cites W2112561886 @default.
• W2899585536 cites W2115602788 @default.
• W2899585536 cites W2121723241 @default.
• W2899585536 cites W2130265908 @default.
• W2899585536 cites W2139248078 @default.
• W2899585536 cites W2154451915 @default.
• W2899585536 cites W2190824129 @default.
• W2899585536 cites W2373606074 @default.
• W2899585536 cites W4255618143 @default.
• W2899585536 doi "https://doi.org/10.1148/radiol.2018180648" @default.
• W2899585536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30398433" @default.
• W2899585536 hasPublicationYear "2019" @default.
• W2899585536 type Work @default.
• W2899585536 sameAs 2899585536 @default.
• W2899585536 citedByCount "48" @default.
• W2899585536 countsByYear W28995855362019 @default.
• W2899585536 countsByYear W28995855362020 @default.
• W2899585536 countsByYear W28995855362021 @default.
• W2899585536 countsByYear W28995855362022 @default.
• W2899585536 countsByYear W28995855362023 @default.
• W2899585536 crossrefType "journal-article" @default.
• W2899585536 hasAuthorship W2899585536A5004120899 @default.
• W2899585536 hasAuthorship W2899585536A5012119257 @default.
• W2899585536 hasAuthorship W2899585536A5024657373 @default.
• W2899585536 hasAuthorship W2899585536A5033299279 @default.
• W2899585536 hasAuthorship W2899585536A5037042906 @default.
• W2899585536 hasAuthorship W2899585536A5070612619 @default.
• W2899585536 hasAuthorship W2899585536A5072853954 @default.
• W2899585536 hasBestOaLocation W28995855361 @default.
• W2899585536 hasConcept C121608353 @default.
• W2899585536 hasConcept C126322002 @default.
• W2899585536 hasConcept C126838900 @default.
• W2899585536 hasConcept C141071460 @default.
• W2899585536 hasConcept C143998085 @default.
• W2899585536 hasConcept C188816634 @default.
• W2899585536 hasConcept C2778822529 @default.
• W2899585536 hasConcept C2779134260 @default.
• W2899585536 hasConcept C2779984678 @default.
• W2899585536 hasConcept C2781156865 @default.
• W2899585536 hasConcept C44249647 @default.
• W2899585536 hasConcept C71924100 @default.
• W2899585536 hasConceptScore W2899585536C121608353 @default.
• W2899585536 hasConceptScore W2899585536C126322002 @default.
• W2899585536 hasConceptScore W2899585536C126838900 @default.
• W2899585536 hasConceptScore W2899585536C141071460 @default.
• W2899585536 hasConceptScore W2899585536C143998085 @default.
• W2899585536 hasConceptScore W2899585536C188816634 @default.
• W2899585536 hasConceptScore W2899585536C2778822529 @default.
• W2899585536 hasConceptScore W2899585536C2779134260 @default.
• W2899585536 hasConceptScore W2899585536C2779984678 @default.
• W2899585536 hasConceptScore W2899585536C2781156865 @default.
• W2899585536 hasConceptScore W2899585536C44249647 @default.
• W2899585536 hasConceptScore W2899585536C71924100 @default.
• W2899585536 hasIssue "2" @default.
• W2899585536 hasLocation W28995855361 @default.
• W2899585536 hasLocation W28995855362 @default.
• W2899585536 hasOpenAccess W2899585536 @default.
• W2899585536 hasPrimaryLocation W28995855361 @default.
• W2899585536 hasRelatedWork W1584669207 @default.
• W2899585536 hasRelatedWork W2024340610 @default.
• W2899585536 hasRelatedWork W2024938637 @default.
• W2899585536 hasRelatedWork W2121180524 @default.
• W2899585536 hasRelatedWork W2899528185 @default.
• W2899585536 hasRelatedWork W2899585536 @default.
• W2899585536 hasRelatedWork W3030034569 @default.
• W2899585536 hasRelatedWork W3031735911 @default.
• W2899585536 hasRelatedWork W3172671185 @default.
• W2899585536 hasRelatedWork W4210287142 @default.
• W2899585536 hasVolume "290" @default.
• W2899585536 isParatext "false" @default.
• W2899585536 isRetracted "false" @default.

• next